Systematic review on the treatment of pentoxifylline in patients with non-alcoholic fatty liver disease

BACKGROUND: As an anti-TNF agent that targets inflammatory process directly, Pentoxifylline has been investigated for treatment of NASH in individual studies and pilot trials for years. We summarized the available information and generating hypotheses for future research. DATA SOURCES: Google, Cochr...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenjun, Zheng, Liu, Sheng, Chunjun, Cheng, Xiaoyun, Qing, Liu, Qu, Shen
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088890/
https://www.ncbi.nlm.nih.gov/pubmed/21477300
http://dx.doi.org/10.1186/1476-511X-10-49

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3088890/
https://www.ncbi.nlm.nih.gov/pubmed/21477300
http://dx.doi.org/10.1186/1476-511X-10-49

Ejemplares similares